Abstract
The original version of this article incorrectly stated the dosage of 6-diazo-5-oxo-L-norleucine (DON) in animal studies. The unit of DON was incorrect; it should be 3 μg/g. There are three errors regarding units of DON in “DON administration study” in Methods, “DON administration reduces tissue O-GlcNAc levels and the MR protein levels in db/db mice” in Results and the caption of Fig. 5E. The original article has been corrected.
| Original language | English |
|---|---|
| Pages (from-to) | 814 |
| Number of pages | 1 |
| Journal | Hypertension Research |
| Volume | 46 |
| Issue number | 3 |
| DOIs |
|
| Publication status | Published - 2023 Mar |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Internal Medicine
- Physiology
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Correction: Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification (Hypertension Research, (2023), 46, 1, (19-31), 10.1038/s41440-022-01036-6)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS